Oritinib mesylate

SI-7841

Oritinib mesylate, >98% (HPLC)

CAS No. : [2180164-79-6]

Synonyms : SH-1028 mesylate

IUPAC Name : N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl)pyrimidin-2-yl)amino)phenyl)acrylamide methanesulfonate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Oritinib mesylate is an orally active, irreversible EGFR inhibitor (IC₅₀ = 18 nM) that potently targets both sensitizing and T790M resistance mutations. It markedly inhibits the growth of tumor cells driven by EGFR‑mutant signaling, highlighting its utility in EGFR‑dependent cancer research.

References : Han L. et al.: Front Pharmacol, 12, 665253, 2021.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.